BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2011
View Archived Issues
Novel CRAC inhibitors presented
Read More
New antibacterial aminoglycoside derivatives claimed
Read More
Merck & Co. patents new gamma-secretase inhibitors
Read More
Merrimack regains rights to nanoliposomal irinotecan from PharmaEngine
Read More
Favorable preclinical data disclosed on HSP 90 inhibitor MPC-3100
Read More
Compound 49b shows promise to treat diabetic retinopathy
Read More
Ophthalmic antimicrobial peptide SESB-88V inhibits ocular pathogens
Read More
Clinical study finds omalizumab ineffective in treating eosinophilic esophagitis
Read More
Intravenous solithromycin is well tolerated in healthy volunteers
Read More
Novel tyrosine-protein kinase JAK inhibitors patented by Pfizer
Read More
Rib-X Pharmaceuticals discloses new antibacterial agents
Read More
New ALK tyrosine kinase receptor inhibitors presented
Read More
Institute of Human Virology receives funding for HIV vaccine candidate FLSC
Read More
Opsona Therapeutics receives EC grant for clinical development of OPN-305
Read More
Chelsea Therapeutics receives approval to open new arm in phase II CH-4051 trial
Read More
Astellas and Medivation begin new phase II MDV-3100 trial in prostate cancer
Read More
MCD-386CR receives FDA orphan drug status in progressive supranuclear palsy
Read More
Wilex completes patient recruitment in phase II Mesupron trial
Read More
Alcon Research begins phase II study of AL-59412C
Read More
Takeda and Pronova report on pivotal Japanese trial of TAK-085 in hypertriglyceridemia
Read More
FDA approves Sanofi Pasteur's new intradermal injection of Fluzone influenza vaccine
Read More
Actikerall enters national approval phase in seven European countries for actinic keratosis
Read More
EpiCept files protocol for confirmatory phase III Ceplene trial in AML
Read More
Bayer's regorafenib receives FDA fast track status in GIST
Read More
CCL21-vaults have antitumor effects in model of lung cancer
Read More